North East and North Cumbria
ICS Formulary
Home
About
Admin
netFormulary
Chapters
Medicines A-Z
News
Mobile
Reports
Feedback
Search
Results
Looking for
Ponatinib
found
4 matches
Open monograph to display formulary status
BNF Category
Ponatinib
(Iclusig
®
)
Malignant disease and immunosuppression - Protein kinase inhibitors - 08.01.05
Links
Link to Drug Section
Link to document
MHRA Drug Safety Update (April 2017): Ponatinib (Iclusig▼): risk of vascular occlusive events—updated advice on possible dose reduction (08.01.05)
MHRA Drug Safety Update (October 2018): Ponatinib (Iclusig▼): reports of posterior reversible encephalopathy syndrome (08.01.05)
NICE TA451 Ponatinib for treating chronic myeloid leukaemia and acute lymphoblastic leukaemia (08.01.05)